China Resources Medical Holdings Company Limited provided consolidated earnings guidance for the year ended December 31, 2021. Based on the information currently available to the Company and the preliminary review on the Group's unaudited consolidated management accounts for the Reporting Period, the Group expects that the profit for the period attributable to owners of the parent company of the Group as contained in the consolidated financial statements for the Reporting Period would increase by approximately 30% as compared with the corresponding period in year 2020. The increase was mainly attributable to the improved profit contribution of member hospitals, resulting from the successful implementation of the Group's strategy in strengthening the management of member hospitals' daily operation and promoting their service quality and operation efficiency, which helped member hospitals effectively cope with the challenges brought about by the new normal with the epidemic and improved their overall financial performance.
China Resources Medical Holdings Company Limited
Equities
1515
KYG2133W1087
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.14 HKD | -0.24% | -3.28% | -14.32% |
05-13 | China Resources Medical to Shutdown Loss-Making Unit | MT |
04-26 | China Resources Medical's 2023 Profit Slides | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.32% | 689M | |
-22.00% | 15.84B | |
+2.70% | 12.38B | |
+4.31% | 11.79B | |
+3.43% | 10.27B | |
+26.63% | 8.51B | |
-8.80% | 7.54B | |
+7.08% | 6.78B | |
0.00% | 5.96B | |
-4.42% | 4.28B |
- Stock Market
- Equities
- 1515 Stock
- News China Resources Medical Holdings Company Limited
- China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021